Profil bibliographique

Dale S. Wright

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

117Publications signalées

450Citations signalées

2Affiliations récentes

Les institutions déclarées

The University of Sydney Children's Hospital at Westmead

Les domaines associés

Indian and Buddhist StudiesChinese history and philosophyAcute Myeloid Leukemia ResearchJapanese History and CultureIndian History and Philosophy

Les publications récentes

Accès ouvert 2025 article OpenAlex

SS18-rearranged false negative FISH synovial sarcoma: A rare case of primary renal synovial sarcoma with cryptic genetic rearrangement

Kai Zong Teo, Dale S. Wright, Lawrence Kim, Phuong Dinh et autres

au (code pays fourni par la source)

0 citations Current Problems in Cancer Case Reports

2025 article OpenAlex

Small cell osteosarcoma with positive NKX2.2 immunohistochemistry staining – a potential pitfall in daily practice

Kai Zong Teo, Dale S. Wright, Ali Moghimi

au (code pays fourni par la source)

0 citations Pathology

Accès ouvert 2023 article OpenAlex

A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma

Angela Chou, Min Qiu, Henry Crayton, Bin Wang et autres

au (code pays fourni par la source)

19 citations Modern Pathology

Accès ouvert 2023 other OpenAlex

Data from Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris et autres

0 citations

Accès ouvert 2023 other OpenAlex

Supp Fig 3 from Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris et autres

0 citations

Accès ouvert 2023 other OpenAlex

Supp Table 1 from Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris et autres

0 citations

Accès ouvert 2023 other OpenAlex

Supp Fig 3 from Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris et autres

0 citations

Accès ouvert 2023 other OpenAlex

Supp Table 2 from Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris et autres

0 citations

Accès ouvert 2023 other OpenAlex

Supp Table 1 from Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris et autres

0 citations

Accès ouvert 2023 other OpenAlex

Supp Figure Legends from Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris et autres

0 citations

Accès ouvert 2023 other OpenAlex

Supp Fig 2 from Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris et autres

0 citations

Accès ouvert 2023 other OpenAlex

Supp Fig 1 from Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Lohith Bachegowda, Kerry Morrone, Shannon L. Winski, Ioannis Mantzaris et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.